Correlation Between Taxus Cardium and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Taxus Cardium and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taxus Cardium and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taxus Cardium Pharmaceuticals and Kymera Therapeutics, you can compare the effects of market volatilities on Taxus Cardium and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taxus Cardium with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taxus Cardium and Kymera Therapeutics.
Diversification Opportunities for Taxus Cardium and Kymera Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Taxus and Kymera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Taxus Cardium Pharmaceuticals and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Taxus Cardium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taxus Cardium Pharmaceuticals are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Taxus Cardium i.e., Taxus Cardium and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Taxus Cardium and Kymera Therapeutics
If you would invest 4,089 in Kymera Therapeutics on November 2, 2024 and sell it today you would lose (44.00) from holding Kymera Therapeutics or give up 1.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 5.26% |
| Values | Daily Returns |
Taxus Cardium Pharmaceuticals vs. Kymera Therapeutics
Performance |
| Timeline |
| Taxus Cardium Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Kymera Therapeutics |
Taxus Cardium and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Taxus Cardium and Kymera Therapeutics
The main advantage of trading using opposite Taxus Cardium and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taxus Cardium position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Taxus Cardium vs. Revolution Medicines | Taxus Cardium vs. Blueprint Medicines Corp | Taxus Cardium vs. Sana Biotechnology | Taxus Cardium vs. Kymera Therapeutics |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |